Debela Dejene Tolossa, Muzazu Seke Gy, Heraro Kidist Digamo, Ndalama Maureen Tayamika, Mesele Betelhiem Woldemedhin, Haile Dagimawi Chilot, Kitui Sophia Khalayi, Manyazewal Tsegahun
Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Enteric Diseases and Vaccines Research Unit, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
SAGE Open Med. 2021 Aug 12;9:20503121211034366. doi: 10.1177/20503121211034366. eCollection 2021.
Cancer is a global health problem responsible for one in six deaths worldwide. Treating cancer has been a highly complex process. Conventional treatment approaches, such as surgery, chemotherapy, and radiotherapy, have been in use, while significant advances are being made in recent times, including stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, chemodynamic therapy, sonodynamic therapy, and ferroptosis-based therapy. Current methods in oncology focus on the development of safe and efficient cancer nanomedicines. Stem cell therapy has brought promising efficacy in regenerating and repairing diseased or damaged tissues by targeting both primary and metastatic cancer foci, and nanoparticles brought new diagnostic and therapeutic options. Targeted therapy possessed breakthrough potential inhibiting the growth and spread of specific cancer cells, causing less damage to healthy cells. Ablation therapy has emerged as a minimally invasive procedure that burns or freezes cancers without the need for open surgery. Natural antioxidants demonstrated potential tracking down free radicals and neutralizing their harmful effects thereby treating or preventing cancer. Several new technologies are currently under research in clinical trials, and some of them have already been approved. This review presented an update on recent advances and breakthroughs in cancer therapies.
SAGE Open Med. 2021-8-12
Pharmaceutics. 2022-6-7
Mol Biol Rep. 2023-11
Eur J Pharm Biopharm. 2015-6
Ecancermedicalscience. 2019
Oncologist. 1997
Cochrane Database Syst Rev. 2018-2-6
Biomedicines. 2025-8-15
Nanomaterials (Basel). 2025-8-6
Nanomaterials (Basel). 2025-7-22
Nat Med. 2021-1
Nanomedicine. 2020-10
Anticancer Agents Med Chem. 2021
Electromagn Biol Med. 2020-4-2
Front Bioeng Biotechnol. 2020-1-10
J Hematol Oncol. 2019-11-28